+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Clinical Diagnostics Market by Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others), by Product, by Application, by End-User by Region, Competition, Forecast & Opportunities, 2026

  • ID: 5238560
  • Report
  • January 2021
  • Region: Global
  • 110 pages
  • TechSci Research
The Global Clinical Diagnostics Market Was Valued at Around USD 56 Billion in 2020 and is Expected to Grow at a Steady CAGR of 8.59% During the Forecast Period.

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Clinical Diagnostics Market was valued at around USD 56 billion in 2020 and is expected to grow at a steady CAGR of 8.59% during the forecast period. The Global Clinical Diagnostics Market is driven by increasing prevalence of diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, among others. Furthermore, increase in the number of patients suffering from chronic kidney diseases and cancer is also expected to drive the market for clinical diagnostics during the forecast years. Additionally, benefits such as quick test results, easy procedure of testing, ease of procurement of samples, less pain, among others associated with clinical diagnostics are further anticipated to propel the market through 2026.

Clinical diagnostics includes medical tests that are performed in a pathology or a diagnostic center or hospital or any other medical facility to diagnose or detect any disease or any other medical conditions. These tests help in early detection of a disease and identify the associated risk factors thereby creating opportunities for prevention and treatment.

The Global Clinical Diagnostics Market can be segmented based on type of test, product, application, end-user, company and region. Based on type of test, the market can be fragmented into lipid panel, metabolic panel, infectious disease testing, complete blood count and others. The lipid panel type of test segment is expected to dominate the market during forecast period owing to the significant increase in the number of people suffering from diseases caused due to obesity and sedentary lifestyle. Additionally, growing risks of cardiovascular diseases and cholesterol related problems is further driving the growth of this segment across the globe. Infectious disease segment is expected to exhibit the highest growth due to increase in prevalence of COVID-19. Based on product, the market can be categorized into instruments, reagents, assays and kits, and software & services. The assays and kits segment is expected to hold a significant market share over the next five years. This can be accredited to the increasing use of assays and kits for COVID-19 testing and in point of care and self-testing product kits.

Among all the regions, North America is expected to dominate the market through 2026. This can be attributed to the increasing health awareness among the population pertaining to the benefits of these tests and flourishing healthcare industry in the region. Asia -Pacific is expected to grow at the highest CAGR due to increasing investments by leading global players as well as and government initiatives.

Major players operating in the Global Clinical Diagnostics Market include Abbott Laboratories, BioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic, Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, DiaSorin SpA, among others.

Years considered for this report:
  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026
Objective of the Study:
  • To analyze and forecast the market size of the Global Clinical Diagnostics Market.
  • To classify and forecast the Global Clinical Diagnostics Market based on type of test, product, application, End-User, and regional distribution.
  • To identify drivers and challenges for the Global Clinical Diagnostics Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Clinical Diagnostics Market.
  • To conduct pricing analysis for the Global Clinical Diagnostics Market.
  • To identify and analyze the profile of leading players operating in the Global Clinical Diagnostics Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of major diagnostic players and hospital chains operating across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research.

The publisher calculated the market size of the Global Clinical Diagnostics Market by using a bottom-up approach, wherein data for various End-User segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Clinical diagnostics hospitals, diagnostic laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to clinical diagnostics
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, diagnostic laboratories and partners, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Global Clinical Diagnostics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Type of Test:
  • Lipid Panel
  • Metabolic Panel
  • Infectious Disease Testing
  • Complete Blood Count
  • Others
Market, By Product:
  • Instruments
  • Reagents
  • Assays and Kits
  • Software & Services
Market, By Application:
  • Infectious Disease
  • Cardiovascular
  • Cancer
  • Others
Market, By End-User:
  • Hospital & Clinics
  • Diagnostic Laboratory
  • Others
Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • South America
  • Brazil
  • Argentina
  • Colombia
Competitive Landscape:
Company Profiles: Detailed analysis of the major companies present in the Global Clinical Diagnostics Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Clinical Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others)
5.2.2. By Product (Instruments, Reagents, Software & Services, Assays & Kits)
5.2.3. By Application (Infectious Diseases, Cardiovascular, Cancer and Others)
5.2.4. By End-User (Hospital & Clinics, Diagnostic Laboratory, Others)
5.2.5. By Company (2020)
5.2.6. By Region
5.3. Product Market Map

6. Asia-Pacific Clinical Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Test
6.2.2. By Product
6.2.3. By Application
6.2.4. By End-User
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. Japan Clinical Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Test
6.3.1.2.2. By Application
6.3.1.2.3. By Product
6.3.1.2.4. By End-User
6.3.2. China Clinical Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Test
6.3.2.2.2. By Application
6.3.2.2.3. By Product
6.3.2.2.4. By End-User
6.3.3. India Clinical Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Test
6.3.3.2.2. By Application
6.3.3.2.3. By Product
6.3.3.2.4. By End-User
6.3.4. South Korea Clinical Diagnostics Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type of Test
6.3.4.2.2. By Application
6.3.4.2.3. By Product
6.3.4.2.4. By End-User
6.3.5. Australia Clinical Diagnostics Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type of Test
6.3.5.2.2. By Application
6.3.5.2.3. By Product
6.3.5.2.4. By End-User
6.3.6. Singapore Clinical Diagnostics Market Outlook
6.3.6.1. Market Size & Forecast
6.3.6.1.1. By Value
6.3.6.2. Market Share & Forecast
6.3.6.2.1. By Type of Test
6.3.6.2.2. By Application
6.3.6.2.3. By Product
6.3.6.2.4. By End-User

7. Europe Clinical Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Test
7.2.2. By Application
7.2.3. By Product
7.2.4. By End-User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Clinical Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Test
7.3.1.2.2. By Application
7.3.1.2.3. By Product
7.3.1.2.4. By End-User
7.3.2. Germany Clinical Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Test
7.3.2.2.2. By Application
7.3.2.2.3. By Product
7.3.2.2.4. By End-User
7.3.3. United Kingdom Clinical Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Test
7.3.3.2.2. By Application
7.3.3.2.3. By Product
7.3.3.2.4. By End-User
7.3.4. Italy Clinical Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Test
7.3.4.2.2. By Application
7.3.4.2.3. By Product
7.3.4.2.4. By End-User
7.3.5. Spain Clinical Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Test
7.3.5.2.2. By Application
7.3.5.2.3. By Product
7.3.5.2.4. By End-User
7.3.6. Russia Clinical Diagnostics Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Type of Test
7.3.6.2.2. By Application
7.3.6.2.3. By Product
7.3.6.2.4. By End-User

8. North America Clinical Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Test
8.2.2. By Product
8.2.3. By Application
8.2.4. By End-User
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Clinical Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Test
8.3.1.2.2. By Application
8.3.1.2.3. By Product
8.3.1.2.4. By End-User
8.3.2. Canada Clinical Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Test
8.3.2.2.2. By Application
8.3.2.2.3. By Product
8.3.2.2.4. By End-User
8.3.3. Mexico Clinical Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Test
8.3.3.2.2. By Application
8.3.3.2.3. By Product
8.3.3.2.4. By End-User

9. South America Clinical Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Test
9.2.2. By Product
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Clinical Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Test
9.3.1.2.2. By Application
9.3.1.2.3. By Product
9.3.1.2.4. By End-User
9.3.2. Argentina Clinical Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Test
9.3.2.2.2. By Application
9.3.2.2.3. By Product
9.3.2.2.4. By End-User
9.3.3. Colombia Clinical Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Test
9.3.3.2.2. By Application
9.3.3.2.3. By Product
9.3.3.2.4. By End-User

10. Middle East and Africa Clinical Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Test
10.2.2. By Product
10.2.3. By Application
10.2.4. By End-User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Clinical Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Test
10.3.1.2.2. By Application
10.3.1.2.3. By Product
10.3.1.2.4. By End-User
10.3.2. Saudi Arabia Clinical Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Test
10.3.2.2.2. By Application
10.3.2.2.3. By Product
10.3.2.2.4. By End-User
10.3.3. UAE Clinical Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Test
10.3.3.2.2. By Application
10.3.3.2.3. By Product
10.3.3.2.4. By End-User
10.3.4. Kuwait Clinical Diagnostics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type of Test
10.3.4.2.2. By Application
10.3.4.2.3. By Product
10.3.4.2.4. By End-User

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. BioMerieux SA
13.2.3. Bio-Rad Laboratories Inc.
13.2.4. Danaher Corporation
13.2.5. Becton, Dickinson and Company
13.2.6. F. Hoffmann-La Roche AG
13.2.7. Hologic, Inc.
13.2.8. Thermo Fisher Scientific Inc.
13.2.9. Sysmex Corporation
13.2.10. DiaSorin SpA

14. Strategic Recommendations

15. About the Publisher & Disclaimer

List of Figures
Figure 1: Global Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
Figure 3: Global Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
Figure 4: Global Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
Figure 6: Global Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
Figure 7: Global Clinical Diagnostic Market Share, By Region (USD Million), 2016-2026F
Figure 8: Global Clinical Diagnostic Market Share, By Company (USD Million), 2016-2026F
Figure 9: Global Clinical Diagnostic Market Attractiveness Index, By Region, By Value, 2016-2026F
Figure 10: Global Clinical Diagnostic Market Attractiveness Index, By Product Type, By Value, 2016-2026F
Figure 11: North America Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 12: North America Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
Figure 13: North America Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
Figure 14: North America Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
Figure 15: North America Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
Figure 16: North America Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
Figure 17: North America Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 18: North America Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 19: United States Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 20: United States Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 21: United States Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 22: United States Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 23: United States Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 24: United States Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 25: Canada Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 26: Canada Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 27: Canada Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 28: Canada Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 29: Canada Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 30: Canada Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 31: Mexico Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 32: Mexico Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 33: Mexico Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 34: Mexico Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 35: Mexico Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 36: Mexico Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 37: Europe Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 38: Europe Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
Figure 39: Europe Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
Figure 40: Europe Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
Figure 41: Europe Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
Figure 42: Europe Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
Figure 43: Europe Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 44: Europe Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 45: France Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 46: France Kingdom Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 47: France Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 48: France Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 49: France Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 50: France Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 51: Germany Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 52: Germany Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 53: Germany Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 54: Germany Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 55: Germany Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 56: Germany Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 57: United Kingdom Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 58: United Kingdom Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 59: United Kingdom Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 60: United Kingdom Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 61: United Kingdom Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 62: United Kingdom Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 63: Italy Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 64: Italy Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 65: Italy Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 66: Italy Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 67: Italy Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 68: Italy Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 69: Spain Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 70: Spain Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 71: Spain Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 72: Spain Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 73: Spain Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 74: Spain Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 75: Russia Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 76: Russia Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 77: Russia Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 78: Russia Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 79: Russia Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 80: Russia Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 81: Asia-Pacific Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 82: Asia-Pacific Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
Figure 83: Asia-Pacific Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
Figure 84: Asia-Pacific Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
Figure 85: Asia-Pacific Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
Figure 86: Asia-Pacific Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
Figure 87: Asia-Pacific Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 88: Asia-Pacific Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 89: Japan Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 90: Japan Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 91: Japan Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 92: Japan Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 93: Japan Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 94: Japan Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 95: China Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 96: China Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 97: China Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 98: China Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 99: China Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 100: China Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 101: India Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 102: India Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 103: India Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 104: India Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 105: India Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 106: India Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 107: South Korea Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 108: South Korea Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 109: South Korea Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 110: South Korea Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 111: South Korea Clinical Diagnostic Market Share, By End-user, 2016-2026F
Figure 112: South Korea Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 113: Australia Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 114: Australia Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 115: Australia Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 116: Australia Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 117: Australia Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 118: Australia Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 119: Singapore Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 120: Singapore Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 121: Singapore Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 122: Singapore Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 123: Singapore Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 124: Singapore Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 125: Middle East and Africa Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 126: Middle East and Africa Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
Figure 127: Middle East and Africa Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
Figure 128: Middle East and Africa Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
Figure 129: Middle East and Africa Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
Figure 130: Middle East and Africa Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
Figure 131: Middle East and Africa Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 132: Middle East and Africa Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 133: South Africa Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 134: South Africa Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 135: South Africa Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 136: South Africa Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 137: South Africa Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 138: South Africa Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 139: SAUDI ARABIA Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 140: SAUDI ARABIA Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 141: SAUDI ARABIA Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 142: SAUDI ARABIA Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 143: SAUDI ARABIA Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 144: SAUDI ARABIA Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 145: UAE Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 146: UAE Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 147: UAE Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 148: UAE Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 149: UAE Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 150: UAE Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 151: Kuwait Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 152: Kuwait Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 153: Kuwait Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 154: Kuwait Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 155: Kuwait Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 156: Kuwait Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 157: South America Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 158: South America Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
Figure 159: South America Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
Figure 160: South America Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
Figure 161: South America Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
Figure 162: South America Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
Figure 163: South America Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 164: South America Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 165: Brazil Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 166: Brazil Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 167: Brazil Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 168: Brazil Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 169: Brazil Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 170: Brazil Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 171: Argentina Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 172: Argentina Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 173: Argentina Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 174: Argentina Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 175: Argentina Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 176: Argentina Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Figure 177: Colombia Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
Figure 178: Colombia Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
Figure 179: Colombia Clinical Diagnostic Market Share, By Product, 2016-2026F
Figure 180: Colombia Clinical Diagnostic Market Share, By Application, 2016-2026F
Figure 181: Colombia Clinical Diagnostic Market Share, By End-User, 2016-2026F
Figure 182: Colombia Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • DiaSorin SpA
Note: Product cover images may vary from those shown
Adroll
adroll